25 XP   0   0   10

DermTech Inc
Buy, Hold or Sell?

Let's analyse Dermtech together

PenkeI guess you are interested in DermTech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of DermTech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about DermTech Inc

I send you an email if I find something interesting about DermTech Inc.

Quick analysis of Dermtech (30 sec.)










What can you expect buying and holding a share of Dermtech? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.65
Expected worth in 1 year
$-0.52
How sure are you?
45.2%

+ What do you gain per year?

Total Gains per Share
$-2.17
Return On Investment
-337.2%

For what price can you sell your share?

Current Price per Share
$0.64
Expected price per share
$0 - $1.12
How sure are you?
50%

1. Valuation of Dermtech (5 min.)




Live pricePrice per Share (EOD)

$0.64

Intrinsic Value Per Share

$-24.93 - $-29.01

Total Value Per Share

$-23.28 - $-27.36

2. Growth of Dermtech (5 min.)




Is Dermtech growing?

Current yearPrevious yearGrowGrow %
How rich?$57.1m$167.3m-$85.9m-105.6%

How much money is Dermtech making?

Current yearPrevious yearGrowGrow %
Making money-$25m-$28.4m$3.4m13.6%
Net Profit Margin-660.3%-792.2%--

How much money comes from the company's main activities?

3. Financial Health of Dermtech (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#83 / 146

Most Revenue
#115 / 146

Most Profit
#123 / 146

Most Efficient
#131 / 146

What can you expect buying and holding a share of Dermtech? (5 min.)

Welcome investor! Dermtech's management wants to use your money to grow the business. In return you get a share of Dermtech.

What can you expect buying and holding a share of Dermtech?

First you should know what it really means to hold a share of Dermtech. And how you can make/lose money.

Speculation

The Price per Share of Dermtech is $0.644. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dermtech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dermtech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.65. Based on the TTM, the Book Value Change Per Share is $-0.54 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.70 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dermtech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.55-85.6%-0.73-113.1%-0.84-130.8%-0.50-77.1%-0.33-51.1%
Usd Book Value Change Per Share-0.46-71.3%-0.54-84.3%-0.70-109.1%-0.12-19.2%0.058.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.46-71.3%-0.54-84.3%-0.70-109.1%-0.12-19.2%0.058.3%
Usd Price Per Share1.75-2.37-6.49-14.16-11.06-
Price to Earnings Ratio-0.79--0.80--1.89--7.49-2.80-
Price-to-Total Gains Ratio-3.81--4.23--8.90--133.33-6,760.53-
Price to Book Ratio1.06-0.99-1.23-11.79-8.08-
Price-to-Total Gains Ratio-3.81--4.23--8.90--133.33-6,760.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.644
Number of shares1552
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.54-0.12
Usd Total Gains Per Share-0.54-0.12
Gains per Quarter (1552 shares)-842.47-191.84
Gains per Year (1552 shares)-3,369.87-767.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3370-33800-767-777
20-6740-67500-1535-1544
30-10110-101200-2302-2311
40-13479-134900-3069-3078
50-16849-168600-3837-3845
60-20219-202300-4604-4612
70-23589-236000-5372-5379
80-26959-269700-6139-6146
90-30329-303400-6906-6913
100-33699-337100-7674-7680

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%3.028.00.09.7%3.028.00.09.7%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%14.015.02.045.2%14.015.02.045.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%14.015.02.045.2%14.015.02.045.2%

Fundamentals of Dermtech

About DermTech Inc

DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 06:09:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of DermTech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dermtech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dermtech to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -486.5% means that $-4.87 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of DermTech Inc:

  • The MRQ is -486.5%. The company is making a huge loss. -2
  • The TTM is -660.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-486.5%TTM-660.3%+173.8%
TTM-660.3%YOY-792.2%+131.9%
TTM-660.3%5Y-623.9%-36.4%
5Y-623.9%10Y-809.0%+185.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-486.5%-8.1%-478.4%
TTM-660.3%-7.5%-652.8%
YOY-792.2%0.3%-792.5%
5Y-623.9%-2.2%-621.7%
10Y-809.0%-2.5%-806.5%
1.1.2. Return on Assets

Shows how efficient Dermtech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dermtech to the Diagnostics & Research industry mean.
  • -15.7% Return on Assets means that Dermtech generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of DermTech Inc:

  • The MRQ is -15.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.7%TTM-16.7%+1.0%
TTM-16.7%YOY-13.4%-3.3%
TTM-16.7%5Y-12.9%-3.8%
5Y-12.9%10Y-12.5%-0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.7%-1.7%-14.0%
TTM-16.7%-1.4%-15.3%
YOY-13.4%-1.2%-12.2%
5Y-12.9%-0.6%-12.3%
10Y-12.5%-0.9%-11.6%
1.1.3. Return on Equity

Shows how efficient Dermtech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dermtech to the Diagnostics & Research industry mean.
  • -33.4% Return on Equity means Dermtech generated $-0.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of DermTech Inc:

  • The MRQ is -33.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -30.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.4%TTM-30.9%-2.5%
TTM-30.9%YOY-17.3%-13.6%
TTM-30.9%5Y-17.9%-13.0%
5Y-17.9%10Y-23.3%+5.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.4%-0.8%-32.6%
TTM-30.9%-0.2%-30.7%
YOY-17.3%-0.2%-17.1%
5Y-17.9%-1.5%-16.4%
10Y-23.3%-2.5%-20.8%

1.2. Operating Efficiency of DermTech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dermtech is operating .

  • Measures how much profit Dermtech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dermtech to the Diagnostics & Research industry mean.
  • An Operating Margin of -503.4% means the company generated $-5.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of DermTech Inc:

  • The MRQ is -503.4%. The company is operating very inefficient. -2
  • The TTM is -684.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-503.4%TTM-684.7%+181.3%
TTM-684.7%YOY-825.1%+140.4%
TTM-684.7%5Y-636.0%-48.6%
5Y-636.0%10Y-825.8%+189.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-503.4%-8.8%-494.6%
TTM-684.7%-0.7%-684.0%
YOY-825.1%4.0%-829.1%
5Y-636.0%2.1%-638.1%
10Y-825.8%-2.0%-823.8%
1.2.2. Operating Ratio

Measures how efficient Dermtech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 6.03 means that the operating costs are $6.03 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of DermTech Inc:

  • The MRQ is 6.034. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.846. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.034TTM7.846-1.812
TTM7.846YOY9.251-1.405
TTM7.8465Y7.272+0.574
5Y7.27210Y4.805+2.466
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0341.315+4.719
TTM7.8461.320+6.526
YOY9.2511.240+8.011
5Y7.2721.275+5.997
10Y4.8051.235+3.570

1.3. Liquidity of DermTech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dermtech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.59 means the company has $4.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of DermTech Inc:

  • The MRQ is 4.592. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.855. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.592TTM5.855-1.263
TTM5.855YOY11.196-5.341
TTM5.8555Y12.035-6.180
5Y12.03510Y10.366+1.669
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5922.194+2.398
TTM5.8552.366+3.489
YOY11.1962.753+8.443
5Y12.0353.035+9.000
10Y10.3663.068+7.298
1.3.2. Quick Ratio

Measures if Dermtech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dermtech to the Diagnostics & Research industry mean.
  • A Quick Ratio of 5.77 means the company can pay off $5.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of DermTech Inc:

  • The MRQ is 5.769. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.112. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.769TTM8.112-2.344
TTM8.112YOY14.271-6.158
TTM8.1125Y14.998-6.886
5Y14.99810Y409.609-394.611
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7691.272+4.497
TTM8.1121.346+6.766
YOY14.2711.564+12.707
5Y14.9981.933+13.065
10Y409.6092.129+407.480

1.4. Solvency of DermTech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dermtech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dermtech to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.53 means that Dermtech assets are financed with 53.1% credit (debt) and the remaining percentage (100% - 53.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of DermTech Inc:

  • The MRQ is 0.531. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.459. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.459+0.072
TTM0.459YOY0.218+0.241
TTM0.4595Y0.242+0.217
5Y0.24210Y0.245-0.003
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5310.416+0.115
TTM0.4590.403+0.056
YOY0.2180.393-0.175
5Y0.2420.450-0.208
10Y0.2450.446-0.201
1.4.2. Debt to Equity Ratio

Measures if Dermtech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dermtech to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 113.3% means that company has $1.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of DermTech Inc:

  • The MRQ is 1.133. The company is able to pay all its debts with equity. +1
  • The TTM is 0.864. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.133TTM0.864+0.269
TTM0.864YOY0.292+0.572
TTM0.8645Y0.412+0.451
5Y0.41210Y0.495-0.083
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1330.606+0.527
TTM0.8640.563+0.301
YOY0.2920.617-0.325
5Y0.4120.637-0.225
10Y0.4950.705-0.210

2. Market Valuation of DermTech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dermtech generates.

  • Above 15 is considered overpriced but always compare Dermtech to the Diagnostics & Research industry mean.
  • A PE ratio of -0.79 means the investor is paying $-0.79 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of DermTech Inc:

  • The EOD is -0.292. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.793. Based on the earnings, the company is expensive. -2
  • The TTM is -0.795. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.292MRQ-0.793+0.501
MRQ-0.793TTM-0.795+0.002
TTM-0.795YOY-1.894+1.099
TTM-0.7955Y-7.490+6.695
5Y-7.49010Y2.796-10.286
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.292-0.268-0.024
MRQ-0.793-0.439-0.354
TTM-0.795-0.368-0.427
YOY-1.894-0.003-1.891
5Y-7.4904.755-12.245
10Y2.7964.908-2.112
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of DermTech Inc:

  • The EOD is -0.444. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.208. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.054. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.444MRQ-1.208+0.763
MRQ-1.208TTM-1.054-0.153
TTM-1.054YOY-2.235+1.181
TTM-1.0545Y-493.579+492.525
5Y-493.57910Y-490.377-3.202
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.444-0.284-0.160
MRQ-1.208-0.534-0.674
TTM-1.054-1.432+0.378
YOY-2.235-2.547+0.312
5Y-493.579-1.847-491.732
10Y-490.377-2.293-488.084
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dermtech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.06 means the investor is paying $1.06 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of DermTech Inc:

  • The EOD is 0.390. Based on the equity, the company is cheap. +2
  • The MRQ is 1.060. Based on the equity, the company is underpriced. +1
  • The TTM is 0.988. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.390MRQ1.060-0.670
MRQ1.060TTM0.988+0.072
TTM0.988YOY1.230-0.242
TTM0.9885Y11.794-10.806
5Y11.79410Y8.079+3.716
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.3901.771-1.381
MRQ1.0602.231-1.171
TTM0.9882.222-1.234
YOY1.2303.239-2.009
5Y11.7943.450+8.344
10Y8.0794.040+4.039
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of DermTech Inc.

3.1. Institutions holding DermTech Inc

Institutions are holding 21.261% of the shares of DermTech Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc4.07010.0001140921720292016.8217
2023-12-31BlackRock Inc1.2560434856-882-0.2024
2023-12-31Hongkou Capital LP1.16260.896940252600
2023-12-31Morgan Stanley - Brokerage Accounts1.1320.0001391936235646150.7748
2023-12-31Geode Capital Management, LLC0.86730.0001300274189536.7371
2023-12-31White Pine Capital LLC0.55910.1306193588-3805-1.9276
2023-12-31King Luther Capital Management Corp0.54730.0016189483-15000-7.3356
2023-12-31Millennium Management LLC0.45460.00011574061574060
2023-12-31Texas Capital Bank Wealth Management Services Inc0.34660.024812000060000100
2023-12-31Stifel Financial Corp0.29470.00021020432108326.0413
2023-12-31State Street Corporation0.273909484900
2023-12-31Susquehanna International Group, LLP0.2475085697-51824-37.6844
2023-12-31Woodmont Investment Counsel LLC0.24330.013884232-12500-12.9223
2023-12-31Northern Trust Corp0.22380774901139017.2315
2023-12-31Bank of New York Mellon Corp0.21710751803471085.7672
2023-12-31JANE STREET GROUP, LLC0.216074788747880
2023-12-31State Treasurer State Of Michigan0.17330.00066000000
2023-12-31Advisor Group Holdings, Inc.0.17130.000259320-650-1.0839
2023-12-31Marshall Wace Asset Management Ltd0.16630.00025757700
2023-12-31Virtu Financial LLC0.15930.007755158551580
Total 12.78211.0774425620+787393+17.8%

3.2. Funds holding DermTech Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.79290.000196700000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.14750.000539728800
2024-02-29Fidelity Extended Market Index0.50230.0006173928-843-0.4823
2023-09-30BlackRock Extended Mkt Composite0.21910.00087584800
2024-03-31BlackRock Extended Equity Market K0.19120.000366195240.0363
2024-03-28iShares Micro-Cap ETF0.18560.00496424800
2024-02-29Fidelity Series Total Market Index0.11650.00014033200
2024-02-29Fidelity Total Market Index0.11480.00013976400
2023-12-31NT Ext Equity Mkt Idx Fd - L0.09550.001330591063847.4466
2023-12-31Northern Trust Extended Eq Market Idx0.09550.001330591063847.4466
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06320.00062188500
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05080.000617577330.1881
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.04830.000116722-775278-97.8886
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.04830.00011672200
2024-02-29Fidelity Nasdaq Composite Index0.04490.00011553800
2024-02-29Vanguard Balanced Index Inv0.0449015536-1578-9.2205
2023-09-30White Pine Capital Small Cap0.04450.701715404-3161-17.0267
2024-03-29Avantis US Small Cap Equity ETF0.04430.00111534800
2024-02-29Spartan Total Market Index Pool E0.03540.00011224500
2024-03-31State St US Extended Mkt Indx NL Cl C0.03350.00041160000
Total 5.9190.71422049298-759527-37.1%

3.3. Insider Transactions

Insiders are holding 4.242% of the shares of DermTech Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-11Kevin M SunSELL4471.45
2023-12-11Claudia IbarraSELL3311.45
2023-12-07Claudia IbarraSELL39111.53
2023-12-07Kevin M SunSELL49791.53
2023-12-07Ramin AkhavanSELL37681.53
2023-09-11Claudia IbarraSELL3221.89
2023-09-11Kevin M SunSELL4361.89
2023-09-08Kevin M SunSELL91801.93
2023-09-08Ramin AkhavanSELL45311.93
2023-09-08Claudia IbarraSELL73781.93
2023-06-12Claudia IbarraSELL3222.85
2023-06-12Kevin M SunSELL4372.85
2023-06-12Todd Michael WoodSELL3502.85
2023-06-07Claudia IbarraSELL39162.53
2023-06-07Kevin M SunSELL49882.53
2023-06-07Ramin AkhavanSELL37762.53
2023-06-07Todd Michael WoodSELL49922.53

4. Summary

4.1. Key Performance Indicators

The key performance indicators of DermTech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.459-0.543+18%-0.703+53%-0.124-73%0.053-961%
Book Value Per Share--1.6512.351-30%4.833-66%3.300-50%3.056-46%
Current Ratio--4.5925.855-22%11.196-59%12.035-62%10.366-56%
Debt To Asset Ratio--0.5310.459+16%0.218+144%0.242+119%0.245+117%
Debt To Equity Ratio--1.1330.864+31%0.292+288%0.412+175%0.495+129%
Dividend Per Share----0%-0%-0%-0%
Eps---0.551-0.728+32%-0.843+53%-0.497-10%-0.329-40%
Free Cash Flow Per Share---0.362-0.562+55%-0.712+96%-0.419+16%-0.273-25%
Free Cash Flow To Equity Per Share---0.363-0.518+43%-0.705+94%-0.118-67%0.065-660%
Gross Profit Margin--1.4411.4470%1.516-5%1.419+2%1.270+13%
Intrinsic Value_10Y_max---29.014--------
Intrinsic Value_10Y_min---24.928--------
Intrinsic Value_1Y_max---2.411--------
Intrinsic Value_1Y_min---2.368--------
Intrinsic Value_3Y_max---7.622--------
Intrinsic Value_3Y_min---7.269--------
Intrinsic Value_5Y_max---13.290--------
Intrinsic Value_5Y_min---12.302--------
Market Cap22297469.600-172%60590950.00081970899.500-26%224619307.500-73%490405837.600-88%383024154.710-84%
Net Profit Margin---4.865-6.603+36%-7.922+63%-6.239+28%-8.090+66%
Operating Margin---5.034-6.847+36%-8.251+64%-6.360+26%-8.258+64%
Operating Ratio--6.0347.846-23%9.251-35%7.272-17%4.805+26%
Pb Ratio0.390-172%1.0600.988+7%1.230-14%11.794-91%8.079-87%
Pe Ratio-0.292+63%-0.793-0.795+0%-1.894+139%-7.490+844%2.796-128%
Price Per Share0.644-172%1.7502.368-26%6.488-73%14.164-88%11.063-84%
Price To Free Cash Flow Ratio-0.444+63%-1.208-1.054-13%-2.235+85%-493.579+40774%-490.377+40509%
Price To Total Gains Ratio-1.403+63%-3.813-4.226+11%-8.902+133%-133.329+3396%6760.526-100%
Quick Ratio--5.7698.112-29%14.271-60%14.998-62%409.609-99%
Return On Assets---0.157-0.167+7%-0.134-14%-0.129-18%-0.125-20%
Return On Equity---0.334-0.309-7%-0.173-48%-0.179-46%-0.233-30%
Total Gains Per Share---0.459-0.543+18%-0.703+53%-0.124-73%0.053-961%
Usd Book Value--57175001.00081389500.250-30%167349750.000-66%114247632.450-50%105826393.487-46%
Usd Book Value Change Per Share---0.459-0.543+18%-0.703+53%-0.124-73%0.053-961%
Usd Book Value Per Share--1.6512.351-30%4.833-66%3.300-50%3.056-46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.551-0.728+32%-0.843+53%-0.497-10%-0.329-40%
Usd Free Cash Flow---12544000.000-19470250.000+55%-24641250.000+96%-14490274.250+16%-9446083.326-25%
Usd Free Cash Flow Per Share---0.362-0.562+55%-0.712+96%-0.419+16%-0.273-25%
Usd Free Cash Flow To Equity Per Share---0.363-0.518+43%-0.705+94%-0.118-67%0.065-660%
Usd Market Cap22297469.600-172%60590950.00081970899.500-26%224619307.500-73%490405837.600-88%383024154.710-84%
Usd Price Per Share0.644-172%1.7502.368-26%6.488-73%14.164-88%11.063-84%
Usd Profit---19091000.000-25028250.000+31%-28429750.000+49%-16920035.500-11%-10935195.889-43%
Usd Revenue--3924000.0003824000.000+3%3629500.000+8%2484500.000+58%1662732.975+136%
Usd Total Gains Per Share---0.459-0.543+18%-0.703+53%-0.124-73%0.053-961%
 EOD+3 -5MRQTTM+20 -14YOY+19 -155Y+11 -2310Y+7 -27

4.2. Fundamental Score

Let's check the fundamental score of DermTech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.292
Price to Book Ratio (EOD)Between0-10.390
Net Profit Margin (MRQ)Greater than0-4.865
Operating Margin (MRQ)Greater than0-5.034
Quick Ratio (MRQ)Greater than15.769
Current Ratio (MRQ)Greater than14.592
Debt to Asset Ratio (MRQ)Less than10.531
Debt to Equity Ratio (MRQ)Less than11.133
Return on Equity (MRQ)Greater than0.15-0.334
Return on Assets (MRQ)Greater than0.05-0.157
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of DermTech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.610
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets121,930
Total Liabilities64,755
Total Stockholder Equity57,175
 As reported
Total Liabilities 64,755
Total Stockholder Equity+ 57,175
Total Assets = 121,930

Assets

Total Assets121,930
Total Current Assets61,752
Long-term Assets60,178
Total Current Assets
Cash And Cash Equivalents 36,741
Short-term Investments 19,123
Net Receivables 2,584
Inventory 1,004
Other Current Assets 2,300
Total Current Assets  (as reported)61,752
Total Current Assets  (calculated)61,752
+/-0
Long-term Assets
Property Plant Equipment 56,710
Long-term Assets Other 3,468
Long-term Assets  (as reported)60,178
Long-term Assets  (calculated)60,178
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,447
Long-term Liabilities51,308
Total Stockholder Equity57,175
Total Current Liabilities
Short-term Debt 3,086
Accounts payable 1,484
Other Current Liabilities 8,681
Total Current Liabilities  (as reported)13,447
Total Current Liabilities  (calculated)13,251
+/- 196
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt51,308
Long-term Liabilities  (as reported)51,308
Long-term Liabilities  (calculated)51,308
+/- 0
Total Stockholder Equity
Common Stock3
Retained Earnings -423,935
Accumulated Other Comprehensive Income 178
Other Stockholders Equity 480,929
Total Stockholder Equity (as reported)57,175
Total Stockholder Equity (calculated)57,175
+/-0
Other
Capital Stock3
Cash and Short Term Investments 55,864
Common Stock Shares Outstanding 34,327
Current Deferred Revenue196
Liabilities and Stockholders Equity 121,930
Net Debt 17,653
Net Invested Capital 57,175
Net Working Capital 48,305
Property Plant and Equipment Gross 60,505
Short Long Term Debt Total 54,394



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302014-06-302014-03-31
> Total Assets 
1,601
2,141
0
0
0
195
146,022
146,234
146,500
146,894
147,405
147,940
148,550
12,440
12,493
23,988
18,211
71,967
64,690
57,025
69,780
265,025
275,700
269,905
248,309
239,522
216,112
194,063
202,075
177,121
157,074
137,896
121,930
121,930137,896157,074177,121202,075194,063216,112239,522248,309269,905275,700265,02569,78057,02564,69071,96718,21123,98812,49312,440148,550147,940147,405146,894146,500146,234146,0221950002,1411,601
   > Total Current Assets 
1,545
2,082
0
0
0
25
843
705
621
543
453
311
86
82
61
23,694
17,150
70,064
62,454
54,534
66,882
261,734
272,248
254,257
232,824
208,124
183,865
160,832
136,037
112,390
93,742
75,929
61,752
61,75275,92993,742112,390136,037160,832183,865208,124232,824254,257272,248261,73466,88254,53462,45470,06417,15023,694618286311453543621705843250002,0821,545
       Cash And Cash Equivalents 
1,346
1,470
0
0
0
25
745
607
554
450
386
234
45
30
15
21,437
15,374
67,922
61,102
14,625
24,248
218,595
229,609
204,061
176,882
145,053
120,333
95,492
77,757
48,438
42,790
37,230
36,741
36,74137,23042,79048,43877,75795,492120,333145,053176,882204,061229,609218,59524,24814,62561,10267,92215,37421,437153045234386450554607745250001,4701,346
       Short-term Investments 
0
0
0
0
0
0
145,178
145,529
145,878
0
0
0
0
0
12,432
0
0
0
0
36,906
39,529
39,603
38,644
45,384
48,449
54,053
53,457
53,636
48,411
56,340
43,406
30,970
19,123
19,12330,97043,40656,34048,41153,63653,45754,05348,44945,38438,64439,60339,52936,906000012,43200000145,878145,529145,178000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
278
437
814
680
1,175
722
1,007
1,480
1,854
2,185
2,819
3,847
4,995
5,962
6,101
4,172
3,690
3,865
3,605
2,584
2,5843,6053,8653,6904,1726,1015,9624,9953,8472,8192,1851,8541,4801,0077221,1756808144372780000000000000
       Other Current Assets 
174
572
0
0
0
0
99
98
67
94
68
78
41
51
46
24
25
127
50
1,881
79
339
134
178
3,166
723
500
643
3,940
2,348
816
530
2,300
2,3005308162,3483,9406435007233,166178134339791,8815012725244651417868946798990000572174
   > Long-term Assets 
0
0
0
0
0
170
145,178
145,529
145,878
146,350
146,952
147,629
148,464
12,358
12,432
294
1,061
1,903
2,236
2,491
2,898
3,291
3,452
15,648
15,485
31,398
32,247
33,231
66,038
64,731
63,332
61,967
60,178
60,17861,96763,33264,73166,03833,23132,24731,39815,48515,6483,4523,2912,8982,4912,2361,9031,06129412,43212,358148,464147,629146,952146,350145,878145,529145,17817000000
       Property Plant Equipment 
20
21
0
0
0
0
0
0
0
0
0
0
0
202
189
210
977
1,736
2,069
2,324
2,731
3,124
3,285
12,457
12,293
28,206
28,610
29,587
62,382
61,062
59,865
58,500
56,710
56,71058,50059,86561,06262,38229,58728,61028,20612,29312,4573,2853,1242,7312,3242,0691,736977210189202000000000002120
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
12,358
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000012,3580000000000000
       Long-term Assets Other 
0
0
0
0
0
170
145,178
145,529
145,878
146,350
146,350
147,629
148,464
12,358
12,432
84
84
167
167
167
167
167
167
3,191
3,192
3,192
167
167
168
168
3,467
3,467
3,468
3,4683,4673,4671681681671673,1923,1923,191167167167167167167848412,43212,358148,464147,629146,350146,350145,878145,529145,17817000000
> Total Liabilities 
1,030
1,330
0
0
0
173
5,089
5,055
5,069
5,073
5,141
5,674
5,780
6,590
6,782
5,094
5,722
5,337
5,762
4,777
6,290
8,198
8,391
17,984
18,611
36,041
37,535
39,075
69,722
69,879
68,997
64,832
64,755
64,75564,83268,99769,87969,72239,07537,53536,04118,61117,9848,3918,1986,2904,7775,7625,3375,7225,0946,7826,5905,7805,6745,1415,0735,0695,0555,0891730001,3301,030
   > Total Current Liabilities 
1,028
1,326
0
0
0
173
58
24
38
42
110
643
749
1,558
2,469
5,094
5,722
5,337
5,762
4,098
5,425
7,097
7,642
10,799
12,181
14,424
15,088
16,986
15,636
16,138
16,014
12,636
13,447
13,44712,63616,01416,13815,63616,98615,08814,42412,18110,7997,6427,0975,4254,0985,7625,3375,7225,0942,4691,558749643110423824581730001,3261,028
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
-643
0
0
116
0
0
0
0
0
109
110
112
1,524
1,574
1,815
1,827
1,712
1,750
1,853
2,313
2,978
3,086
3,0862,9782,3131,8531,7501,7121,8271,8151,5741,5241121101090000011600-64300000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
7,316
9,697
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000009,6977,3160000000000000
       Accounts payable 
444
656
0
0
0
4
54
13
27
31
99
632
713
1,522
2,353
1,004
1,609
1,561
813
819
1,573
2,621
2,104
2,504
2,880
1,575
861
2,997
2,419
1,680
2,324
1,703
1,484
1,4841,7032,3241,6802,4192,9978611,5752,8802,5042,1042,6211,5738198131,5611,6091,0042,3531,52271363299312713544000656444
       Other Current Liabilities 
20
6
0
0
0
168
4
11
11
11
11
643
36
36
116
2,633
2,723
2,683
3,932
2,274
2,838
3,009
4,054
5,414
6,347
9,684
11,090
11,860
11,358
12,363
11,082
7,719
8,681
8,6817,71911,08212,36311,35811,86011,0909,6846,3475,4144,0543,0092,8382,2743,9322,6832,7232,6331163636643111111114168000620
   > Long-term Liabilities 
0
0
0
0
0
4
5,031
5,031
5,031
5,031
5,031
5,031
5,031
5,031
4,313
2,461
2,999
2,654
1,830
679
865
1,101
749
7,185
6,430
21,617
22,447
22,089
54,086
53,741
52,983
52,196
51,308
51,30852,19652,98353,74154,08622,08922,44721,6176,4307,1857491,1018656791,8302,6542,9992,4614,3135,0315,0315,0315,0315,0315,0315,0315,031400000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
643
0
0
-116
0
0
0
0
0
226
198
170
6,777
6,284
21,488
22,423
22,069
54,081
53,729
52,977
52,195
51,308
51,30852,19552,97753,72954,08122,06922,42321,4886,2846,77717019822600000-1160064300000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
226
968
747
7,185
6,430
21,617
22,447
22,089
54,086
53,741
52,983
0
0
0052,98353,74154,08622,08922,44721,6176,4307,18574796822600000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
639
133
2
0
0
0
0
0
0
0
0
0
0
0000000000213363900000000000000000000
> Total Stockholder Equity
559
797
0
0
0
22
140,932
141,179
141,430
141,820
142,264
142,266
142,770
5,850
5,711
18,894
12,489
66,630
58,928
52,248
63,490
256,827
267,309
251,921
229,698
203,481
178,577
154,988
132,353
107,242
88,077
73,064
57,175
57,17573,06488,077107,242132,353154,988178,577203,481229,698251,921267,309256,82763,49052,24858,92866,63012,48918,8945,7115,850142,770142,266142,264141,820141,430141,179140,93222000797559
   Common Stock
1
1
0
0
0
25
140,967
140,967
140,967
140,967
140,967
140,967
140,967
4,052
4,052
1
1
1
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3333333333332221114,0524,052140,967140,967140,967140,967140,967140,967140,9672500011
   Retained Earnings Total Equity00-385,680-354,317-323,047-294,824-266,052-236,472-206,364-180,311-160,199-143,097-126,36000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-23,988
-239
-71,967
-64,690
-57,025
-1
8
2
-8
-124
-694
-865
-1,095
-774
-289
-101
127
178
178127-101-289-774-1,095-865-694-124-828-1-57,025-64,690-71,967-239-23,988000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,889
103,599
164,741
0
0
189,849
399,913
427,503
432,237
436,183
440,644
445,491
450,904
456,171
461,845
473,855
0
0
00473,855461,845456,171450,904445,491440,644436,183432,237427,503399,913189,84900164,741103,599104,889000000000000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,889
103,599
164,741
166,455
169,163
189,849
399,913
427,503
432,237
436,183
440,644
445,491
450,904
456,171
461,845
473,855
477,778
480,929
480,929477,778473,855461,845456,171450,904445,491440,644436,183432,237427,503399,913189,849169,163166,455164,741103,599104,889000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue15,296
Cost of Revenue-15,020
Gross Profit276276
 
Operating Income (+$)
Gross Profit276
Operating Expense-104,015
Operating Income-103,739-103,739
 
Operating Expense (+$)
Research Development15,239
Selling General Administrative43,781
Selling And Marketing Expenses44,995
Operating Expense104,015104,015
 
Net Interest Income (+$)
Interest Income2,846
Interest Expense-0
Other Finance Cost-0
Net Interest Income2,846
 
Pretax Income (+$)
Operating Income-103,739
Net Interest Income2,846
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-100,888-106,590
EBIT - interestExpense = -103,739
-100,888
-100,888
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-103,739-100,888
Earnings Before Interest and Taxes (EBITDA)-97,893
 
After tax Income (+$)
Income Before Tax-100,888
Tax Provision-0
Net Income From Continuing Ops-100,888-100,888
Net Income-100,888
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses119,035
Total Other Income/Expenses Net2,851-2,846
 

Technical Analysis of Dermtech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dermtech. The general trend of Dermtech is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dermtech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of DermTech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.61 < 0.73 < 1.12.

The bearish price targets are: .

Tweet this
DermTech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of DermTech Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

DermTech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of DermTech Inc.

DermTech Inc Daily Moving Average Convergence/Divergence (MACD) ChartDermTech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of DermTech Inc. The current adx is .

DermTech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of DermTech Inc.

DermTech Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of DermTech Inc.

DermTech Inc Daily Relative Strength Index (RSI) ChartDermTech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of DermTech Inc.

DermTech Inc Daily Stochastic Oscillator ChartDermTech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of DermTech Inc.

DermTech Inc Daily Commodity Channel Index (CCI) ChartDermTech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of DermTech Inc.

DermTech Inc Daily Chande Momentum Oscillator (CMO) ChartDermTech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of DermTech Inc.

DermTech Inc Daily Williams %R ChartDermTech Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of DermTech Inc.

DermTech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of DermTech Inc.

DermTech Inc Daily Average True Range (ATR) ChartDermTech Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of DermTech Inc.

DermTech Inc Daily On-Balance Volume (OBV) ChartDermTech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of DermTech Inc.

DermTech Inc Daily Money Flow Index (MFI) ChartDermTech Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for DermTech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

DermTech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of DermTech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.610
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dermtech with someone you think should read this too:
  • Are you bullish or bearish on Dermtech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dermtech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about DermTech Inc

I send you an email if I find something interesting about DermTech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about DermTech Inc.

Receive notifications about DermTech Inc in your mailbox!